H. pylori

2022 - 12 - 16

Post cover
Image courtesy of "GlobeNewswire"

Helicobacter Pylori Testing Global Market Report 2022: Featuring ... (GlobeNewswire)

Dublin, Dec. 15, 2022 (GLOBE NEWSWIRE) -- The "Helicobacter Pylori Testing: Global Market Outlook" report has been added to ResearchAndMarkets.com's...

Asia-Pacific is currently the fastest-growing market for Helicobacter pylori testing for the forecast period. In this report, the global Helicobacter pylori testing market is segmented based on test type, end user and geography. By geography, the Helicobacter pylori testing market is segmented into North America, Europe, Asia-Pacific, and Rest of the World. pylori infection in the geriatric population, and growing demand for point-of-care testing devices are the key factors driving the growth of the Helicobacter pylori testing market. Using 2021 as the base year, the report provides estimated market data for the forecast period of 2022 to 2027. Market values are estimated based on the total revenue of H.

Post cover
Image courtesy of "BMC Gastroenterology"

Application of a WeChat-based mini-app as a patient reminder in Helicobacter pylori eradication: a prospective multi ... (BMC Gastroenterology)

Helicobacter pylori (H. pylori) is a major human pathogen related to a variety of diseases from chronic gastritis, peptic ulcer disease, gastric atrophy, to malignancies like gastric adenocarcinoma and gastric mucosa-associated lymphoid tissue (MALT) ...

pylori eradication rates [ [21](/articles/10.1186/s12876-022-02614-1#ref-CR21), [23](/articles/10.1186/s12876-022-02614-1#ref-CR23), [24](/articles/10.1186/s12876-022-02614-1#ref-CR24)]. [3](/articles/10.1186/s12876-022-02614-1#ref-CR3), [21](/articles/10.1186/s12876-022-02614-1#ref-CR21)]. [19](/articles/10.1186/s12876-022-02614-1#ref-CR19)]. [15](/articles/10.1186/s12876-022-02614-1#ref-CR15)]. pylori eradication rates [ [16](/articles/10.1186/s12876-022-02614-1#ref-CR16)]. 71.2%, p = 0.036) [ [14](/articles/10.1186/s12876-022-02614-1#ref-CR14)]. [1](/articles/10.1186/s12876-022-02614-1#MOESM1) and Additional file [2](/articles/10.1186/s12876-022-02614-1#MOESM2): Fig. There were no significant differences in the patients’ baseline characteristics between two groups (Table [1](/articles/10.1186/s12876-022-02614-1#Tab1)). [16](/articles/10.1186/s12876-022-02614-1#ref-CR16), [17](/articles/10.1186/s12876-022-02614-1#ref-CR17)], the expected value of eradication rate in the DMN group and in the control group was 90% and 75%, respectively. [1](/articles/10.1186/s12876-022-02614-1#ref-CR1)]. pylori eradication and patient compliance [ [14](/articles/10.1186/s12876-022-02614-1#ref-CR14), [15](/articles/10.1186/s12876-022-02614-1#ref-CR15)]. The research was registered in the Chinese Clinical Trial Registry (ChiCTR2000031011, 21/03/2020).

Explore the last week